These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30661768)

  • 1. Protamine to expedite vascular hemostasis after catheter ablation of atrial fibrillation: A randomized controlled trial.
    Ghannam M; Chugh A; Dillon P; Alyesh D; Kossidas K; Sharma S; Coatney J; Atreya A; Yokokawa M; Saeed M; Cunnane R; Ghanbari H; Latchamsetty R; Crawford T; Jongnarangsin K; Bogun F; Pelosi F; Morady F; Oral H
    Heart Rhythm; 2018 Nov; 15(11):1642-1647. PubMed ID: 30661768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of the concomitant use of heparin on the effects of warfarin during catheter ablation for atrial fibrillation.
    Inada K; Matsuo S; Tokutake K; Yokoyama K; Hioki M; Narui R; Ito K; Tanigawa S; Yamashita S; Tokuda M; Shibayama K; Miyanaga S; Sugimoto K; Yoshimura M; Yamane T
    Heart Vessels; 2016 Mar; 31(3):397-401. PubMed ID: 25471944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin reversal with protamine sulfate is not required in atrial fibrillation ablation with suture hemostasis.
    Yasar SJ; Bickel T; Zhang S; Akkaya M; Aznaurov SG; Krishnan K; Cuculich PS; Gautam S
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2811-2817. PubMed ID: 31661173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin.
    Shin DG; Kim TH; Uhm JS; Kim JY; Joung B; Lee MH; Pak HN
    Yonsei Med J; 2016 Mar; 57(2):342-9. PubMed ID: 26847285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study.
    Kuwahara T; Abe M; Yamaki M; Fujieda H; Abe Y; Hashimoto K; Ishiba M; Sakai H; Hishikari K; Takigawa M; Okubo K; Takagi K; Tanaka Y; Nakajima J; Takahashi A
    J Cardiovasc Electrophysiol; 2016 May; 27(5):549-54. PubMed ID: 26766541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation (COMPARE) randomized trial.
    Di Biase L; Burkhardt JD; Santangeli P; Mohanty P; Sanchez JE; Horton R; Gallinghouse GJ; Themistoclakis S; Rossillo A; Lakkireddy D; Reddy M; Hao S; Hongo R; Beheiry S; Zagrodzky J; Rong B; Mohanty S; Elayi CS; Forleo G; Pelargonio G; Narducci ML; Dello Russo A; Casella M; Fassini G; Tondo C; Schweikert RA; Natale A
    Circulation; 2014 Jun; 129(25):2638-44. PubMed ID: 24744272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periprocedural outcomes of protamine administration after catheter ablation of atrial fibrillation.
    Kewcharoen J; Shah K; Bhardwaj R; Contractor T; Turagam MK; Mandapati R; Lakkireddy D; Garg J
    Rev Cardiovasc Med; 2022 Jan; 23(1):34. PubMed ID: 35092226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of Intraprocedural Anticoagulation in Patients on Non-Vitamin K Antagonist Oral Anticoagulants Undergoing Catheter Ablation for Atrial Fibrillation: Understanding the Gaps in Evidence.
    Martin AC; Godier A; Narayanan K; Smadja DM; Marijon E
    Circulation; 2018 Aug; 138(6):627-633. PubMed ID: 30354610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short-Term Heparin Kinetics during Catheter Ablation of Atrial Fibrillation.
    Gabus V; Rollin A; Maury P; Forclaz A; Pascale P; Dhutia H; Bisch L; Pruvot E
    Pacing Clin Electrophysiol; 2015 Oct; 38(10):1142-50. PubMed ID: 26014444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Periprocedural anticoagulation of patients undergoing pericardiocentesis for cardiac tamponade complicating catheter ablation of atrial fibrillation.
    Lin T; Bai R; Chen YW; Yu RH; Tang RB; Sang CH; Li SN; Ma CS; Dong JZ
    Int Heart J; 2015; 56(1):56-61. PubMed ID: 25503659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preprocedural therapeutic international normalized ratio influence on bleeding complications in atrial fibrillation ablation with continued anticoagulation with warfarin.
    Hayashi T; Kumagai K; Naito S; Goto K; Kaseno K; Ohshima S; Hachiya H; Hirao K; Isobe M
    Circ J; 2013; 77(2):338-44. PubMed ID: 23090638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Periprocedural outcomes of prophylactic protamine administration for reversal of heparin after cryoballoon ablation of atrial fibrillation.
    Conte G; de Asmundis C; Baltogiannis G; Di Giovanni G; Ciconte G; Sieira J; Saitoh Y; Wauters K; Mugnai G; Julià J; Irfan G; Levinstein M; Cotino-Moreno HE; Chierchia GB; Brugada P
    J Interv Card Electrophysiol; 2014 Nov; 41(2):129-34. PubMed ID: 24938637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation.
    Kim JS; She F; Jongnarangsin K; Chugh A; Latchamsetty R; Ghanbari H; Crawford T; Suwanagool A; Sinno M; Carrigan T; Kennedy R; Saint-Phard W; Yokokawa M; Good E; Bogun F; Pelosi F; Morady F; Oral H
    Heart Rhythm; 2013 Apr; 10(4):483-9. PubMed ID: 23237911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in activated clotting time among uninterrupted anticoagulants during the periprocedural period of atrial fibrillation ablation.
    Nagao T; Inden Y; Yanagisawa S; Kato H; Ishikawa S; Okumura S; Mizutani Y; Ito T; Yamamoto T; Yoshida N; Hirai M; Murohara T
    Heart Rhythm; 2015 Sep; 12(9):1972-8. PubMed ID: 25881495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of apixaban in the patients undergoing the ablation of atrial fibrillation.
    Nagao T; Inden Y; Shimano M; Fujita M; Yanagisawa S; Kato H; Ishikawa S; Miyoshi A; Okumura S; Ohguchi S; Yamamoto T; Yoshida N; Hirai M; Murohara T
    Pacing Clin Electrophysiol; 2015 Feb; 38(2):155-63. PubMed ID: 25487164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uninterrupted Direct Oral Anticoagulant and Warfarin Administration in Elderly Patients Undergoing Catheter Ablation for Atrial Fibrillation: A Comparison With Younger Patients.
    Yanagisawa S; Inden Y; Fujii A; Ando M; Funabiki J; Murase Y; Takenaka M; Otake N; Ikai Y; Sakamoto Y; Shibata R; Murohara T
    JACC Clin Electrophysiol; 2018 May; 4(5):592-600. PubMed ID: 29798785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Uninterrupted Periprocedural Edoxaban in Patients Undergoing Catheter Ablation for Atrial Fibrillation　- The Prospective KYU-RABLE Study.
    Takahashi N; Mukai Y; Kimura T; Yamaguchi K; Matsumoto T; Origasa H; Okumura K;
    Circ J; 2019 Sep; 83(10):2017-2024. PubMed ID: 31511436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation.
    Gunawardene M; Willems S; Schäffer B; Moser J; Akbulak RÖ; Jularic M; Eickholt C; Nührich J; Meyer C; Kuklik P; Sehner S; Czerner V; Hoffmann BA
    Clin Res Cardiol; 2017 Jan; 106(1):38-48. PubMed ID: 27435077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periprocedural anticoagulation during left atrial ablation: interrupted and uninterrupted vitamin K-antagonists or uninterrupted novel anticoagulants.
    Brinkmeier-Theofanopoulou M; Tzamalis P; Wehrkamp-Richter S; Radzewitz A; Merkel M; Schymik G; van Mark G; Bramlage P; Schmitt C; Luik A
    BMC Cardiovasc Disord; 2018 Apr; 18(1):71. PubMed ID: 29703158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immediate post-procedure bridging with unfractioned heparin versus low molecular weight heparin in patients undergoing radiofrequency ablation for atrial fibrillation with an interrupted oral anticoagulation strategy.
    Loughlin G; Romaniega TD; Garcia-Fernandez J; Calvo D; Salgado R; Alonso A; Li X; Arenal A; González-Torrecilla E; Atienza F; Fernández-Avilés F
    J Interv Card Electrophysiol; 2016 Mar; 45(2):149-58. PubMed ID: 26739484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.